Spire Healthcare Group (LON:SPI) Shares Up 8.8% - Still a Buy?

Key Points

• Spire Healthcare Group's stock experienced an 8.8% increase during trading, reaching a last traded price of GBX 235.50 ($3.19), with a significant surge in trading volume at over 9 million shares.
• Analyst ratings for Spire Healthcare are generally positive, with three analysts giving a Buy rating and a consensus price target of GBX 294.33, despite JPMorgan decreasing their target to GBX 303.
• The company reported an EPS of GBX 4.10 for the last quarter, with analysts forecasting an annual EPS of approximately 15.66, indicating potential growth for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares shot up 8.8% during trading on Friday . The stock traded as high as GBX 237.50 ($3.20) and last traded at GBX 235.50 ($3.17). 9,013,502 shares changed hands during mid-day trading, an increase of 515% from the average session volume of 1,465,043 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analysts Set New Price Targets

Several research firms recently commented on SPI. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 280 price objective on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. cut their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of GBX 294.33.

Spire Healthcare Group Stock Performance

The company's fifty day simple moving average is GBX 218.75 and its 200 day simple moving average is GBX 203.56. The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The stock has a market capitalization of £993.86 million, a P/E ratio of 5,369.57, a P/E/G ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, sell-side analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.